Bausch Health Cos Other Long-Term Assets 2010-2024 | BHC
Bausch Health Cos other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Bausch Health Cos Annual Other Long-Term Assets (Millions of US $) |
2023 |
$307 |
2022 |
$326 |
2021 |
$340 |
2020 |
$664 |
2019 |
$411 |
2018 |
$109 |
2017 |
$111 |
2016 |
$2,316 |
2015 |
$224 |
2014 |
$167 |
2013 |
$196 |
2012 |
$184 |
2011 |
$59 |
2010 |
$37 |
2009 |
$33 |
Bausch Health Cos Quarterly Other Long-Term Assets (Millions of US $) |
2024-09-30 |
$389 |
2024-06-30 |
$329 |
2024-03-31 |
$312 |
2023-12-31 |
$307 |
2023-09-30 |
$328 |
2023-06-30 |
$325 |
2023-03-31 |
$318 |
2022-12-31 |
$326 |
2022-09-30 |
$341 |
2022-06-30 |
$338 |
2022-03-31 |
$334 |
2021-12-31 |
$340 |
2021-09-30 |
$343 |
2021-06-30 |
$596 |
2021-03-31 |
$617 |
2020-12-31 |
$664 |
2020-09-30 |
$345 |
2020-06-30 |
$367 |
2020-03-31 |
$411 |
2019-12-31 |
$411 |
2019-09-30 |
$402 |
2019-06-30 |
$360 |
2019-03-31 |
$377 |
2018-12-31 |
$109 |
2018-09-30 |
$108 |
2018-06-30 |
$124 |
2018-03-31 |
$107 |
2017-12-31 |
$111 |
2017-09-30 |
$870 |
2017-06-30 |
$820 |
2017-03-31 |
$1,591 |
2016-12-31 |
$2,316 |
2016-09-30 |
$214 |
2016-06-30 |
$219 |
2016-03-31 |
$211 |
2015-12-31 |
$224 |
2015-09-30 |
$236 |
2015-06-30 |
$167 |
2015-03-31 |
$171 |
2014-12-31 |
$167 |
2014-09-30 |
$233 |
2014-06-30 |
$206 |
2014-03-31 |
$186 |
2013-12-31 |
$196 |
2013-09-30 |
$242 |
2013-06-30 |
$199 |
2013-03-31 |
$180 |
2012-12-31 |
$184 |
2012-09-30 |
$106 |
2012-06-30 |
$98 |
2012-03-31 |
$87 |
2011-12-31 |
$59 |
2011-09-30 |
$58 |
2011-06-30 |
$54 |
2011-03-31 |
$56 |
2010-12-31 |
$37 |
2010-09-30 |
$28 |
2010-06-30 |
$29 |
2010-03-31 |
$31 |
2009-12-31 |
$33 |
2009-09-30 |
$34 |
2009-06-30 |
$40 |
2009-03-31 |
$19 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$3.009B |
$8.757B |
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|